Stratec SE/€SBS
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Stratec SE
STRATEC SE, headquartered in Birkenfeld, Germany, specializes in designing and manufacturing fully automated analyzer systems, software, and smart consumables for the in-vitro diagnostics and life sciences sectors. Founded in 1979, the company operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on automated analyzer systems for clinical diagnostics and biotechnology clients; the Diatron segment offers systems and consumables for low-throughput hematology and clinical chemistry applications; and the Smart Consumables segment develops polymer-based consumables for diagnostics and medical applications. STRATEC primarily serves as an original equipment manufacturer (OEM), collaborating with diagnostic companies to develop products marketed under their brands. The company's global presence includes facilities in Switzerland, the United States, Romania, Hungary, Austria, and China. Its strategic positioning is reinforced by long-term partnerships with leading in-vitro diagnostics companies and a comprehensive technology portfolio that spans the entire value chain, from design and development to regulatory approval and production. (,)
Ticker
€SBS
Sector
Primary listing
XETRA
Employees
1,420
Headquarters
Website
Stratec SE Metrics
BasicAdvanced
€214m
-
-€0.02
-
€0.60
3.31%
Price and volume
Market cap
€214m
52-week high
€32.90
52-week low
€16.36
Average daily volume
4k
Dividend rate
€0.60
Financial strength
Current ratio
3.971
Quick ratio
1.84
Interest coverage (TTM)
2.19%
Profitability
EBITDA (TTM)
33.927
Gross margin (TTM)
25.60%
Net profit margin (TTM)
-0.10%
Operating margin (TTM)
3.66%
Effective tax rate (TTM)
104.99%
Revenue per employee (TTM)
€180,000
Management effectiveness
Return on assets (TTM)
1.32%
Return on equity (TTM)
-0.10%
Valuation
Price to revenue (TTM)
0.878
Price to book
0.9
Price to tangible book (TTM)
1.65
Price to free cash flow (TTM)
-13.212
Free cash flow yield (TTM)
-7.57%
Free cash flow per share (TTM)
-1.371
Dividend yield (TTM)
3.31%
Forward dividend yield
3.31%
Growth
Revenue change (TTM)
-2.62%
Earnings per share change (TTM)
-101.52%
3-year revenue growth (CAGR)
-2.97%
10-year revenue growth (CAGR)
5.50%
3-year earnings per share growth (CAGR)
-79.73%
10-year earnings per share growth (CAGR)
-36.41%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Stratec SE stock?
Stratec SE (SBS) has a market cap of €214M as of May 05, 2026.
What is the P/E ratio for Stratec SE stock?
The price to earnings (P/E) ratio for Stratec SE (SBS) stock is 0 as of May 05, 2026.
Does Stratec SE stock pay dividends?
Yes, the Stratec SE (SBS) stock pays dividends to shareholders. As of May 05, 2026, the dividend rate is €0.6 and the yield is 3.31%. Stratec SE has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Stratec SE dividend payment date?
The next Stratec SE (SBS) dividend payment is scheduled for June 26, 2026.
What is the beta indicator for Stratec SE?
Stratec SE (SBS) does not currently have a Beta indicator.